PMID- 2548078 OWN - NLM STAT- MEDLINE DCOM- 19890921 LR - 20210526 IS - 0270-7306 (Print) IS - 1098-5549 (Electronic) IS - 0270-7306 (Linking) VI - 9 IP - 6 DP - 1989 Jun TI - Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells. PG - 2303-14 AB - Abundant expression of herpes simplex virus type 1 glycoprotein gC (gC1) in transfected mammalian cells has not previously been achieved, possibly because gC1 protein is toxic to cells. To approach this problem, the gC1 coding sequence was placed under the control of the weak but inducible glucocorticoid-responsive promoter from the mouse mammary tumor virus (MMTV) long terminal repeat (LTR). As controls to evaluate for gC1 cytotoxicity, the MMTV LTR promoter was used to express glycoprotein gD1, and a strong, constitutive promoter from the Moloney murine sarcoma virus LTR was used to express gC1. L cells were transfected with these constructs, and a clone expressing gC1 from the inducible MMTV LTR promoter was analyzed. In the absence of glucocorticoid (dexamethasone) stimulation, only a low level of gC1 mRNA expression was detected; after overnight stimulation with dexamethasone, transcription increased approximately 200-fold. Abundant gC1 protein that was functionally active in that it bound complement component C3b, was produced. From passages 5 through 26 (70 cell population doublings), the gC1-producing clone became less responsive to overnight dexamethasone stimulation. The block to gC1 expression occurred at the level of transcription and was associated with hypermethylation of the MMTV LTR DNA. Treatment of the clone with 5-aza-2'-deoxycytidine partially reversed the block in gC1 protein production. Late-passage cells assumed a gC1-negative phenotype that appeared to offer a selective growth advantage, which suggested that gC1 was cytotoxic. Several findings support this view: (i) some cells expressing gC1 after overnight stimulation with dexamethasone assumed bizarre, syncytial shapes; (ii) continuous stimulation with dexamethasone for 5 weeks resulted in death of most cells; (iii) cells transfected with gC1 under the control of the strong Moloney murine sarcoma virus promoter assumed bizarre shapes, and stable gC1-expressing clones could not be established; and (iv) cells induced to express gD1 retained a normal appearance after overnight stimulation or 15 weeks of continuous stimulation with dexamethasone. The inducible MMTV LTR promoter is useful for expressing gC1 and may have applications for expressing other cytotoxic proteins. FAU - Friedman, H M AU - Friedman HM AD - Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia. FAU - Yee, A AU - Yee A FAU - Diggelmann, H AU - Diggelmann H FAU - Hastings, J C AU - Hastings JC FAU - Tal-Singer, R AU - Tal-Singer R FAU - Seidel-Dugan, C A AU - Seidel-Dugan CA FAU - Eisenberg, R J AU - Eisenberg RJ FAU - Cohen, G H AU - Cohen GH LA - eng GR - AI-18289/AI/NIAID NIH HHS/United States GR - FO6 TWO1162/TW/FIC NIH HHS/United States GR - HL 28220/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Mol Cell Biol JT - Molecular and cellular biology JID - 8109087 RN - 0 (Cytotoxins) RN - 0 (DNA, Viral) RN - 0 (Glucocorticoids) RN - 0 (RNA, Messenger) RN - 0 (RNA, Viral) RN - 0 (Viral Envelope Proteins) RN - 0 (glycoprotein D, Human herpesvirus 1) RN - 0 (glycoprotein gC, herpes simplex virus type 1) RN - 7S5I7G3JQL (Dexamethasone) SB - IM MH - Animals MH - Cells, Cultured MH - Cloning, Molecular MH - Cytotoxins/biosynthesis/*genetics MH - DNA, Viral/genetics MH - Dexamethasone/*pharmacology MH - *Genes, Viral MH - Glucocorticoids/*genetics MH - Immunoblotting MH - Mammary Tumor Virus, Mouse/genetics MH - Plasmids MH - Promoter Regions, Genetic/*drug effects MH - RNA, Messenger/biosynthesis/genetics MH - RNA, Viral/biosynthesis/genetics MH - Simplexvirus/drug effects/*genetics MH - Transfection MH - Viral Envelope Proteins/biosynthesis/*genetics PMC - PMC362303 EDAT- 1989/06/01 00:00 MHDA- 1989/06/01 00:01 PMCR- 1989/06/01 CRDT- 1989/06/01 00:00 PHST- 1989/06/01 00:00 [pubmed] PHST- 1989/06/01 00:01 [medline] PHST- 1989/06/01 00:00 [entrez] PHST- 1989/06/01 00:00 [pmc-release] AID - 10.1128/mcb.9.6.2303-2314.1989 [doi] PST - ppublish SO - Mol Cell Biol. 1989 Jun;9(6):2303-14. doi: 10.1128/mcb.9.6.2303-2314.1989.